Peptides stocked at phaseonelabz peptides
17 peptides currently tracked
Small-molecule NNMT inhibitor researched for fat cell metabolism, NAD+ salvage pathway regulation, and metabolic health.
Neuroprotective octapeptide from ADNP researched for microtubule stabilization and cognitive preservation.
Synthetic 15-amino acid peptide derived from a gastric protein, researched for tissue repair, gut healing, tendon rec…
Long-acting amylin receptor agonist developed by Novo Nordisk, researched for appetite regulation and weight manageme…
Nine-amino acid neuropeptide researched for sleep regulation, stress adaptation, and normalization of disturbed sleep…
Synthetic tetrapeptide (Ala-Glu-Asp-Gly) researched for telomerase activation, telomere elongation, and potential ant…
Copper-binding tripeptide researched for skin regeneration, wound healing, collagen stimulation, and anti-aging effects.
Four-peptide research blend — GHK-Cu, BPC-157, TB-500 and KPV in one vial.
Anti-inflammatory tripeptide from α-MSH researched for gut health, skin barrier repair, and NF-κB inhibition.
A metabolic and longevity-oriented stack combining 5-Amino-1MQ, MOTS-c, and NAD⁺ — three compounds aimed at cellular …
Mitochondrial-derived peptide researched for metabolic regulation, exercise mimicry, insulin sensitivity, and longevity.
Melanocortin receptor agonist (bremelanotide) FDA-approved as Vyleesi® for hypoactive sexual desire disorder in preme…
Synthetic heptapeptide derived from tuftsin, researched for anxiolytic effects, immune modulation, and cognitive enha…
Synthetic heptapeptide derived from ACTH(4-10), researched for neuroprotection, cognitive enhancement, and brain inju…
Mitochondria-targeted tetrapeptide researched for restoring cellular energy production, reducing oxidative stress, an…
Synthetic growth hormone-releasing hormone (GHRH) analog, FDA-approved as Egrifta® for HIV-associated lipodystrophy. …